Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy

NAActive, not recruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DEVICE

FreeStyle Libre 2 Flash Glucose Monitoring System

Glucose sensors to be worn continuously for 3 months with data used to monitor and manage diabetes treatment and to inform lifestyle choices (diet and exercise)

Trial Locations (8)

Unknown

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari

ASL Toscana Nordovest, Carrara

Università degli Studi di Catania, Ospedale Garibaldi-Nesima, U.O. Endocrinologia, Catania

Università degli Studi di Catania, Ospedale Garibaldi-Nesima, U.O.C. Medicina Interna, Catania

"Azienda Ospedaliero- Universitaria Renato Dulbecco di Catanzaro", Catanzaro

ASL Toscana Nord Ovest, Livorno

Azienda Ospedaliero-Universitaria di Parma, Parma

La Sapienza Università di Roma, AOU Policlinico Umberto I, Rome

Sponsors
All Listed Sponsors
lead

Abbott Diabetes Care

INDUSTRY